News
Adjuvantix announces TB partnerships with HPA and Institut Pasteur, May 2009
Adjuvantix Initiates development of ADX40- Prostate Cancer
"UK Biotech companies join forces to develop novel prostate cancer vaccine" May, 2009
Adjuvantix appoints Dr Paul Jenkins and Dr Philip Bedford as Directors, February 2009
Adjuvantix completes financing round; Yorkshire Cancer Research invests in Adjuvantix, February 2009
